Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. - Wikidata - awgldk - TriplyDB

Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.

Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.

http://www.wikidata.org/entity/Q34506545

about

Considerations in the development of nonhuman primate models of combination antiretroviral therapy for studies of AIDS virus suppression, residual virus, and curative strategies Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.SHIV susceptibility changes during the menstrual cycle of pigtail macaques.Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques.Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaques Increased susceptibility to vaginal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis Pharmacokinetic profile of raltegravir, elvitegravir and dolutegravir in plasma and mucosal secretions in rhesus macaques Macaque models of enhanced susceptibility to HIV.Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques Short Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIVSF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling.Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.Nondaily preexposure prophylaxis for HIV prevention.Tenofovir Disoproxil Fumarate Fails to Prevent HIV Acquisition or the Establishment of a Viral Reservoir: Two Case Reports.Combination Emtricitabine and Tenofovir Disoproxil Fumarate Prevents Vaginal Simian/Human Immunodeficiency Virus Infection in Macaques Harboring Chlamydia trachomatis and Trichomonas vaginalis Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model.Pharmacokinetic and safety analyses of tenofovir and tenofovir-emtricitabine vaginal tablets in pigtailed macaques.On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection.Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.Chemoprophylaxis With Oral Emtricitabine and Tenofovir Alafenamide Combination Protects Macaques From Rectal Simian/Human Immunodeficiency Virus Infection.The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge.Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy.Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05).Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal SHIV Exposures in Macaques.Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV.HIV-1 Drug Resistance in Pre-exposure Prophylaxis Trials

P2860

Q26825814-52B1D85E-B0C1-407A-BF4F-FAF841519C6A Q28079025-69B01CAE-07A1-40FE-9DB9-DAEB9039351C Q28550108-4666A591-8D99-427A-BFCE-CE8A382D2E17 Q28553127-42E291A4-2EE6-42B5-993A-51A38C358C09 Q34034418-8D1AF787-DFEA-445E-9D67-3145760BFA0E Q34057568-623A82B0-BE61-4CC9-99F1-A45F9A1C142D Q34243579-E9D8FFB4-49A4-442A-BF4E-081E11B4AB7A Q34399723-C355A2EE-F0DB-4C15-B89D-A8AB4469DEC6 Q34421999-905D85F0-403E-4EF6-9B48-5237C95E4EB4 Q34478248-3B57A300-AAB7-4B9F-BCA5-C5F9014D90D1 Q34736553-9A2EE901-CF9C-439C-9DC5-A007126F0DFB Q35432739-EBDDE485-4DFF-4B3A-A60E-E7CECEA33E61 Q35776556-C0A02B5C-D0EC-4261-B05E-6A8B9E6BDCFC Q35798274-0F58A0A3-6367-4BF8-A24F-F79C1A4A0E5C Q35927290-C43754DD-03A4-4559-A77E-031A01E70AD5 Q36259499-54AD34B1-A51F-45B4-883F-A00D1A1C365A Q36290753-81BB6FD0-B635-4F88-9244-19B3AB1C3D8A Q36306935-3D76C80F-B951-4746-BC81-384E58EF4922 Q36669377-8AFAAF44-265B-4BF1-A5BF-AF295D2120F1 Q36739989-D32BA48F-320D-4B0F-B7A9-4EE5BDA9D6A9 Q36816612-694CC955-C9AF-4ACC-AAEE-4CE03143C240 Q37123335-F22BA3CC-7EAE-412F-8F71-1474B7F228A1 Q37146567-55DF4B14-C7B7-4062-B85A-3A68A47F48A5 Q37218578-1B878069-7C45-4B33-AE4B-F5D09AC93769 Q37618260-F2C44E7F-9C6C-4799-BB1E-7CA1113429C2 Q37713043-68574B9C-F920-4E2E-8E2E-F38E8B40E86B Q38692324-716F30EA-139D-4FD3-8C24-178103BFE602 Q38936872-58BC10FB-B262-4B58-A8FD-6D4641F91F95 Q40597405-AA9EF0CF-7242-459C-B38E-10E6FCF0AA5A Q41544436-44F2091B-D683-430A-92D8-315E4154D27A Q45326424-8DBD0F9A-ED28-4754-8A28-AEF192E7FED6 Q47398084-932519AB-37DD-4940-B416-3FE85EA7CD55 Q50028271-381E15E7-2E6D-428D-96E4-D2631716359C Q54202671-CEF91024-5382-4EB5-AD60-FA107E6A941D Q54247462-A47C6523-F66E-4A6F-A8A5-A0B858B2E553 Q57207278-851BD93F-E0AD-45F6-9F6E-EFB07F4952B8

P2860

Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen.

http://www.wikidata.org/entity/Q34506545

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@ast

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@en

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@nl

type

label

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@ast

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@en

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@nl

prefLabel

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@ast

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@en

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@nl

P1433

Q34506545-7CB62740-E5ED-4E73-ACB8-B264C488671E

P1476

Q34506545-01688CCF-D42D-400E-9F22-0E97BE524E9C

P2093

Q34506545-2764AC43-E102-40B8-A688-53EA48CCC9BC

Q34506545-64D82377-6EF7-4C57-81D6-7A8386929C14

Q34506545-6910E9D7-A7DE-4AEB-B4FD-912422180815

Q34506545-8917D2A5-2877-4E7D-BB14-ACA51B8F7F8B

Q34506545-9558C49C-C312-4859-87FC-5DEB9864E045

Q34506545-A413FC7D-6F87-4CB0-BB89-BFE94013D3F8

Q34506545-B287AFB6-26C2-4347-B8D8-CEB7FBA87171

Q34506545-C365D04E-439D-41CA-8F19-CE198155E781

Q34506545-FD68C4FB-77B4-402E-ADFE-DEE8F4689C43

P2860

Q34506545-0E52F137-A50C-45BC-BC88-15995630265D

Q34506545-1688631E-8759-4128-9C30-F1A4C3A303D3

Q34506545-26699E3F-5BFD-448F-89EB-1424D12AB16C

Q34506545-2C7A05F2-6410-4245-9515-970BDB3DDD83

Q34506545-311EC82B-15F0-490A-9705-69E87FFD531E

Q34506545-3767CFB7-52AC-4D23-ADC1-1F51FF27996C

Q34506545-3D562643-C974-46DA-9A80-DED4C855C388

Q34506545-3DC17848-7793-44E3-AEA7-6A28D105CFB1

Q34506545-488F6E0A-D9B9-46C1-9CA4-75B600BF78F0

Q34506545-49CE4518-D4F8-4483-99D4-C14DB4BF77A9

P304

Q34506545-1A47483E-6F69-4FFD-9400-551E4807BD7A

P31

Q34506545-AF77906C-A3E1-4BDC-A696-210AF4688164

P356

Q34506545-547CBD2C-F1E4-4E9E-99BD-BEB271623CE2

P407

Q34506545-F520E60A-40F7-4DBA-927C-0011030A62FC

P433

Q34506545-FBB68FA3-626A-4240-B4C8-57168D1999FC

P478

Q34506545-29D8B810-62AA-44D0-BB51-4F7F51A8CE53

P50

Q34506545-873743A1-3D5C-4316-AA50-3F77A39ACEBD

P577

Q34506545-F8CAA0A2-F68A-4C34-A281-B862A80D100D

P5875

Q34506545-D5953501-6A75-40C8-BA73-0EA7705C8609

P698

Q34506545-669443A5-5D65-4420-9218-9D6729CD0C6F

P932

Q34506545-C29CC1CC-0F1A-4860-B834-4F406074D970

P356

JOURNAL.PONE.0050632

P1433

P1476

Prevention of vaginal SHIV tra ...... lly-dependent Truvada regimen.

@en

P2093

Amy Martin

http://www.w3.org/2001/XMLSchema#string

Angela Holder

http://www.w3.org/2001/XMLSchema#string

Chou-Pong Pau

http://www.w3.org/2001/XMLSchema#string

Elizabeth Sweeney

http://www.w3.org/2001/XMLSchema#string

J Gerardo García-Lerma

http://www.w3.org/2001/XMLSchema#string

James Mitchell

http://www.w3.org/2001/XMLSchema#string

Jessica Radzio

http://www.w3.org/2001/XMLSchema#string

Shanon Bachman

http://www.w3.org/2001/XMLSchema#string

Wutyi Aung

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers

Tenofovir-based pre-exposure prophylaxis for HIV prevention

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

Preexposure prophylaxis for HIV infection among African women

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

Early events in sexual transmission of HIV and SIV and opportunities for interventions.

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

P304

e50632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0050632

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233889144

http://www.w3.org/2001/XMLSchema#string

P698

23226529

http://www.w3.org/2001/XMLSchema#string

P932

3514231

http://www.w3.org/2001/XMLSchema#string